Aurobindo Pharma
Aurobindo Pharma News
Dr. Reddy’s becomes India’s second biggest drugmaker; details here
Ankush Mahajan, analyst at Axis Securities stated that Dr Reddy’s is presently investing in various businesses that could offer long term growth
BCCI expecting two new IPL teams to go for Rs 7-10K crore with Adani, Goenka, Aurobindo in fray
It is still not clear whether the BCCI will announce the successful bidders on Monday itself after doing the technical evaluation of the bids.
Emerging landscape of COVID-19 vaccines in India, 14 Aug: Bharat Bio, Zydus move to Phase 2; Biological E, Bayor College tie up for COVID-19 vaccine
Over a dozen Indian companies are in partnership with other firms and institutes to bring a preventive vaccine into global markets by 2021.
Aurobindo Pharma, Sandoz Inc mutually call off $900 mn deal of generic oral solids, dermatology businesses
Aurobindo Pharma on Thursday said the $900 million deal to acquire Sandoz Inc's US-based generic oral solids and dermatology businesses, has been mutually called off
Aurobindo Pharma's net profit rises 4.6% at Rs 639.5 crore in Q2, revenues grow nearly 18%
Formulation revenues for the quarter posted a growth of 21.8% YoY to Rs 4,793.8 crore and accounted for 85.6% of total revenues.
Indian firms remain heavily taxed, how South Asia can contribute a third of global growth; all this and more on Moneycontrol Pro
The corporate tax cut was hailed as a big game-changer for Indian companies.
AstraZeneca moves US court against Aurobindo Pharma on generic version of patented drug Daliresp
Daliresp is a prescription medicine used in adults with severe Chronic Obstructive Pulmonary Disease
Novartis sells parts of Sandoz US to Aurobindo Pharma for $900 mn; Swiss drugmaker to focus on higher growth areas
The 131-year-old Sandoz unit was hurt by price pressure in the United States, prompting Novartis Chief Executive Officer Vas Narasimhan to sell the Sandoz unit.
Aurobindo Pharma gets US FDA's notice on 7 violations with drug making at Hyderabad unit
US FDA’s form 483 to Aurobindo Pharma Hyderabad unit has seven observations relating to violation of good manufacturing practices
Rayalaseema's royal war: Will Chandrababu Naidu wipe out YSR's legacy by ruining Jagan Reddy?
An uneven but pitched, dirty war is being fought between Andhra Pradesh Chief Minister Chandrababu Naidu and Leader of Opposition YS Jaganmohan Reddy and the stakes are sky high.
Aurobindo Pharma receives nod from USFDA for manufacturing cholesterol tablets
Aurobindo Pharma has received approval from the USFDA to manufacture and market Fenofibrate tablets, used for the treatment of high level of cholesterol.
Awaiting Greece crisis outcome, Sensex ends 75 points lower; oil PSUs buck trend
Market breadth, howeve, ended higher with 1,519 stocks advancing against 1,251 declines on BSE.
India scraps import duties on AIDS drugs to battle shortage in Naco efforts
Government officials have previously said about a lack of participation by local drugmakers in the tenders floated by the Naco to procure drugs.
CCEA clears Glenmark, Aurobindo foreign funding proposals worth Rs 4,187 cr
The decision was taken by the Cabinet Committee on Economic Affairs, chaired by Prime Minister Narendra Modi.
FIPB clears 11 FDI proposals, refers Glenmark, Aurobindo deals to CCEA
FIPB has cleared foreign invest in 11 entities, worth Rs 1,075.91 cr, referred proposals worth Rs 4,187 crore in firms - Glenmark and Aurobindo - to CCEA
Aurobindo Pharma to raise $350 mn through QIP
The board had earlier constituted a securities issue committee comprising of five board members, including two independent directors, for issue of securities.
Hyderabad shooting: Constable who tried to kidnap top pharma director, arrested
In an incident where the man had opened fire at the director of Aurobindo Pharma with a stolen AK-47 has been arrested near Hyderabad, police said.
Aurobindo Pharma's director shot at in Hyderabad, shooter leaves behind AK 47
Aurobindo Pharma's director K Nityananda Reddy was shot at in Hyderabad by a man carrying an AK-47 rifle in the posh Banjara Hills area this morning.
Aurobindo Pharma eyes $2 bn revenues in FY15, plans foreign expansions
The consolidated revenue (net) from operations was higher over the previous year by 38.3% at nearly Rs 8,100 crore ($1.4 billon at Rs 58 per dollar) during 2013-14 as against Rs 5,855 crore in the previous year.<br />
Aurobindo Pharma to buy Actavis' loss-making operations in 7 EU nations
Drug maker Aurobindo Pharma has agreed to buy Dublin-based Actavis Plc's commercial operations in seven western European countries for about 30 million euros, in a bid to increase its international footprint.<br /><br />